U.S., March 13 -- ClinicalTrials.gov registry received information related to the study (NCT07465601) titled 'Daily Activity and Clinical Outcome Measurement of Arthrosamid(R) Administration in Symptomatic Knee Osteoarthritis.' on March 06.
Brief Summary: This study is a prospective, monocentric, interventional post-market study evaluating the effects of a single intra-articular injection of Arthrosamid in patients with symptomatic knee osteoarthritis. Arthrosamid is a polyacrylamide hydrogel consisting of 97.5% sterile water and 2.5% cross-linked polyacrylamide that integrates into the synovial tissue and is used for the symptomatic treatment of knee osteoarthritis.
The study will include 30 eligible patients receiving a single Arthrosam...